3,5-Diphenyl-1H-pyrazole derivatives. XII. N-substituted 4-amino-1-(2-hydroxy- or 2-alkylaminoethyl)-3,5-diphenyl-1H-pyrazoles with local anesthetic, analgesic and platelet antiaggregating activities. 1994

O Bruno, and A Ranise, and F Bondavalli, and S Schenone, and M D'Amico, and M Falciani, and C Vacca, and A Filippelli
Istituto di Scienze Farmaceutiche dell'Università, Genova, Italy.

The synthesis of 4-amino-3,5-diphenyl-1H-pyrazole-1-ethanol, as well as of their N-methyl, N-ethyl and N,N-dimethyl derivatives is described. A series of 1-(2-alkylaminoethyl)-3,5-diphenyl-1H-pyrazole-4-amines and of N-substituted 4-dimethylamino-3,5-diphenyl-1H-pyrazole-1-ethanamines were also prepared. Some of the above compounds showed remarkable local anesthetic, analgesic and in vitro platelet antiaggregating activities, as well as moderate antiinflammatory and antipyretic activities in rats and mice.

UI MeSH Term Description Entries
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D000779 Anesthetics, Local Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. Anesthetics, Conduction-Blocking,Conduction-Blocking Anesthetics,Local Anesthetic,Anesthetics, Topical,Anesthetic, Local,Anesthetics, Conduction Blocking,Conduction Blocking Anesthetics,Local Anesthetics,Topical Anesthetics
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

O Bruno, and A Ranise, and F Bondavalli, and S Schenone, and M D'Amico, and M Falciani, and C Vacca, and A Filippelli
April 1993, Farmaco (Societa chimica italiana : 1989),
O Bruno, and A Ranise, and F Bondavalli, and S Schenone, and M D'Amico, and M Falciani, and C Vacca, and A Filippelli
April 1990, Farmaco (Societa chimica italiana : 1989),
O Bruno, and A Ranise, and F Bondavalli, and S Schenone, and M D'Amico, and M Falciani, and C Vacca, and A Filippelli
December 1992, Farmaco (Societa chimica italiana : 1989),
O Bruno, and A Ranise, and F Bondavalli, and S Schenone, and M D'Amico, and M Falciani, and C Vacca, and A Filippelli
January 2015, Acta crystallographica. Section C, Structural chemistry,
O Bruno, and A Ranise, and F Bondavalli, and S Schenone, and M D'Amico, and M Falciani, and C Vacca, and A Filippelli
January 1995, Farmaco (Societa chimica italiana : 1989),
O Bruno, and A Ranise, and F Bondavalli, and S Schenone, and M D'Amico, and M Falciani, and C Vacca, and A Filippelli
November 1988, Il Farmaco; edizione scientifica,
O Bruno, and A Ranise, and F Bondavalli, and S Schenone, and M D'Amico, and M Falciani, and C Vacca, and A Filippelli
April 2008, Archiv der Pharmazie,
O Bruno, and A Ranise, and F Bondavalli, and S Schenone, and M D'Amico, and M Falciani, and C Vacca, and A Filippelli
February 1990, Farmaco (Societa chimica italiana : 1989),
O Bruno, and A Ranise, and F Bondavalli, and S Schenone, and M D'Amico, and M Falciani, and C Vacca, and A Filippelli
June 1972, Journal of pharmaceutical sciences,
O Bruno, and A Ranise, and F Bondavalli, and S Schenone, and M D'Amico, and M Falciani, and C Vacca, and A Filippelli
January 2010, Acta crystallographica. Section E, Structure reports online,
Copied contents to your clipboard!